search
Back to results

Motivational Approach to Treat Childhood Obesity (OBEMAT20)

Primary Purpose

Childhood Obesity, Metabolic Syndrome, Body Composition

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Obemat2.0 therapy
Regular practise in primary care
Sponsored by
Institut Investigacio Sanitaria Pere Virgili
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Childhood Obesity focused on measuring Childhood Obesity, Motivational therapy

Eligibility Criteria

8 Years - 15 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age range between 8 and <14 years at enrolment (so that, children would end the treatment at maximum age of 15 years
  • BMI > 97th percentile of Hernandez references from 1988 (Hernández et al., 1988) as indicated by the Guidelines for Clinical Practice of the Spanish Health System (Grupo de trabajo de la Guía de Práctica Clínica sobre la Prevención y el Tratamiento de la Obesidad Infantojuvenil. Ministerio de Ciencia e Innovación [Spanish Ministry of Sciencee and Innovation], 2009) for the diagnose of the childhood obesity.

Exclusion Criteria:

  • Children with eating disorders
  • Families not available to attend to scheduled visits
  • Simultaneous participation in another clinical trial
  • Presence of endocrine disorders (GH disorder, hypothyroidism, Cushing's disease, early puberty or other)
  • Lack of command of local languages

Sites / Locations

  • Faculty of Medicine, C/ Sant Llorenç 21
  • Iispv- Hospital Sant Joan de Reus
  • IDIAP Jordi Gol
  • Hospital de Tarragona Joan XXIII

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Obemat2.0 Intervention Group

Control Group

Arm Description

Intervention: Obemat2.0 therapy (11 Motivational Interview Visits, 3 Workshops) Duration: 12 months (+3 months). Setting: Primary care centers Providers: pediatritians and nurses trained to perform motivational interview Visits description: The interviews follow a structure: 1. Checking the accomplishment of objectives to congratulate and motivate the patient. 2. A specific topic per visit is explained to the participant and family. 3. A task related to the topic (i.e. to plan a weekly menu for the family) is given to be brought back at the next visit. 4th. Objectives about diet, weight and physical activity are defined to be accomplished until the next visit. The follow-up of the structure is ensured by means of a printed material that the therapists provide each visit to participants.

Control Intervention: regular practise in primary care (11 individual monthly visits) Duration: 12 months (+3 months). Setting: Primary care centers. Providers: standard pediatritians and nurses Children and their families receive the usual recommendations conducted in primary care centers based on the Clinical Practice Guidelines on the Prevention and Treatment of Child and Adolescent Obesity. At visits, the family receive explanations about carrying out a balanced diet, divided into 5 meals, to provide a moderate energy reduction from the previous intake. An increase in physical activity, both in terms of leisure activity, as sports regular practise is recommended. Monthly visits are organized in which weight and height are measured and compliance with advice is reviewed.

Outcomes

Primary Outcome Measures

Body Mass Index z-score
Changes in BMI z-score between the baseline visit and the final assessment

Secondary Outcome Measures

Abdominal obesity (waist circumference)
Changes in waist circumference (cm) between the baseline visit and the final assessment
Abdominal obesity (waist to height)
Changes in waist-to-height circumference (ratio) between the baseline visit and the final assessment
Body composition: fat mass (kg)
Changes in fat mass (kg) between the baseline visit and the final assessment
Body composition: lean mass (kg)
Changes in lean mass (kg) between the baseline visit and the final assessment
Body composition: fat mass index (kg/m2)
Changes in fat mass index between the baseline visit and the final assessment
Body composition: lean mass index (kg/m2)
Changes in lean mass index between the baseline visit and the final assessment
HOMA-IR
Changes in insulin resistance between the baseline visit and the final assessment
Blood Pressure
Changes in systolic and diastoli blood pressure (s-score) between the baseline visit and the final assessment
Tryglycerides
Changes in tryglycerides (mg/dl) between the baseline visit and the final assessment

Full Information

First Posted
October 8, 2018
Last Updated
September 15, 2020
Sponsor
Institut Investigacio Sanitaria Pere Virgili
Collaborators
Institut Català de la Salut, Hospital Universitari Joan XXIII de Tarragona., Hospital Universitari Sant Joan de Reus, Instituto de Salud Carlos III, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, University Rovira i Virgili
search

1. Study Identification

Unique Protocol Identification Number
NCT03749200
Brief Title
Motivational Approach to Treat Childhood Obesity
Acronym
OBEMAT20
Official Title
Clinical and Metabolic Efficacy of the Motivational Approach, Coordinated Between Primary Care and the Clinical Health Services for Childhood Obesity Treatment: Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
December 30, 2020 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institut Investigacio Sanitaria Pere Virgili
Collaborators
Institut Català de la Salut, Hospital Universitari Joan XXIII de Tarragona., Hospital Universitari Sant Joan de Reus, Instituto de Salud Carlos III, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, University Rovira i Virgili

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The treatment of childhood obesity is challenging. Although dietary and physical activity recommendations are widely known, the willingness to change lifestyles within the family is not easy to be achieved. Motivational interviewing has been shown as a possibly effective method to increase adherence to dietary recommendations in the obese adult. There is scarce evidence showing whether implementing a motivational interview in obese children could be effective. The aim of this clinical trial is assessing the effect of a motivational interview, coordinated between the clinical and primary care services on 8 to 14 years old obese children.
Detailed Description
In a recent study, the investigators have demonstrated that the motivational therapy approach to treat childhood obesity is highly effective at clinical and metabolic levels. This efficacy has been proved in a clinical outpatient setting. However, a standardized collaborative approach between the clinic and the primary care services would allow a faster and easier approach to childhood obesity treatment. Furthermore, this motivational and educational intervention would benefit from the current technologic facilities, the long term effect of the education at group level, in terms of food shopping plan, healthy, fast and easy cooking methods. The aim of this clinical trial is to test the efficacy of a multicomponent motivational intervention for the treatment of childhood obesity, coordinated between primary care and hospital specialized services, integrating motivational individual interviews, educational groups and eHealth tools (wearable), compared to the usual intervention performed in paediatrics. The design will be a clustered randomized control trial, with an intervention group that will receive a multicomponent motivational and educational plan which will be compared to a control group receiving the usual recommendations performed in primary care centres (n=167 per group). The treatment of both study groups will last 12 months and will be performed at the primary care centres. In parallel, the study team will validate the methodology used to assess body composition in obese children as well as the changes produced by the intervention. Children assigned to the control group receive advices as recommended by the Clinical Practice Guidelines (17). At visits, the family receive explanations about carrying out a balanced diet, divided into 5 meals, in order to provide a moderate energy intake reduction. An increase in physical activity, both in terms of leisure activity, as sports regular practise are recommended. Monthly visits are organized in which weight and height are measured, and compliance with recommendations are actually taking place. Children assigned to the intervention group receive similar recommendations to those in the control group but under a motivational interview schema. This means that each visit, objectives from the last visit are fulfiled, the therapists try to make the family recongnizing the changes to be done by themselves, rather than imposing by demonstrating ambivalences, and objectives for the next visit are agreed. Furthermore, three workshops as group therapy are organized with the following topics: 1. Increasing physical actty sing an eHEalth monitor, 2. Food choices and dietary balance, and 3. Cooking methods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Childhood Obesity, Metabolic Syndrome, Body Composition
Keywords
Childhood Obesity, Motivational therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clustered clinical trial, with treatment on obese children in 2 arms: a control group (CG) that will follow the usual recommendations of pediatricians and nurses in the primary care centres and an intervention group (IG) that will receive a structured motivation-based interview combined with group therapy and eHealth. the treatment of the two arms will last 12 (+3) months
Masking
None (Open Label)
Masking Description
Given the nature of the intervention participants or researchers could not be blinded.
Allocation
Randomized
Enrollment
319 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Obemat2.0 Intervention Group
Arm Type
Experimental
Arm Description
Intervention: Obemat2.0 therapy (11 Motivational Interview Visits, 3 Workshops) Duration: 12 months (+3 months). Setting: Primary care centers Providers: pediatritians and nurses trained to perform motivational interview Visits description: The interviews follow a structure: 1. Checking the accomplishment of objectives to congratulate and motivate the patient. 2. A specific topic per visit is explained to the participant and family. 3. A task related to the topic (i.e. to plan a weekly menu for the family) is given to be brought back at the next visit. 4th. Objectives about diet, weight and physical activity are defined to be accomplished until the next visit. The follow-up of the structure is ensured by means of a printed material that the therapists provide each visit to participants.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
Control Intervention: regular practise in primary care (11 individual monthly visits) Duration: 12 months (+3 months). Setting: Primary care centers. Providers: standard pediatritians and nurses Children and their families receive the usual recommendations conducted in primary care centers based on the Clinical Practice Guidelines on the Prevention and Treatment of Child and Adolescent Obesity. At visits, the family receive explanations about carrying out a balanced diet, divided into 5 meals, to provide a moderate energy reduction from the previous intake. An increase in physical activity, both in terms of leisure activity, as sports regular practise is recommended. Monthly visits are organized in which weight and height are measured and compliance with advice is reviewed.
Intervention Type
Other
Intervention Name(s)
Obemat2.0 therapy
Intervention Type
Other
Intervention Name(s)
Regular practise in primary care
Primary Outcome Measure Information:
Title
Body Mass Index z-score
Description
Changes in BMI z-score between the baseline visit and the final assessment
Time Frame
12 (+3) months
Secondary Outcome Measure Information:
Title
Abdominal obesity (waist circumference)
Description
Changes in waist circumference (cm) between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Abdominal obesity (waist to height)
Description
Changes in waist-to-height circumference (ratio) between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Body composition: fat mass (kg)
Description
Changes in fat mass (kg) between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Body composition: lean mass (kg)
Description
Changes in lean mass (kg) between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Body composition: fat mass index (kg/m2)
Description
Changes in fat mass index between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Body composition: lean mass index (kg/m2)
Description
Changes in lean mass index between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
HOMA-IR
Description
Changes in insulin resistance between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Blood Pressure
Description
Changes in systolic and diastoli blood pressure (s-score) between the baseline visit and the final assessment
Time Frame
12 (+3) months
Title
Tryglycerides
Description
Changes in tryglycerides (mg/dl) between the baseline visit and the final assessment
Time Frame
12 (+3) months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age range between 8 and <14 years at enrolment (so that, children would end the treatment at maximum age of 15 years BMI > 97th percentile of Hernandez references from 1988 (Hernández et al., 1988) as indicated by the Guidelines for Clinical Practice of the Spanish Health System (Grupo de trabajo de la Guía de Práctica Clínica sobre la Prevención y el Tratamiento de la Obesidad Infantojuvenil. Ministerio de Ciencia e Innovación [Spanish Ministry of Sciencee and Innovation], 2009) for the diagnose of the childhood obesity. Exclusion Criteria: Children with eating disorders Families not available to attend to scheduled visits Simultaneous participation in another clinical trial Presence of endocrine disorders (GH disorder, hypothyroidism, Cushing's disease, early puberty or other) Lack of command of local languages
Facility Information:
Facility Name
Faculty of Medicine, C/ Sant Llorenç 21
City
Reus
State/Province
Tarragona
ZIP/Postal Code
43201
Country
Spain
Facility Name
Iispv- Hospital Sant Joan de Reus
City
Reus
State/Province
Tarragona
ZIP/Postal Code
E43204
Country
Spain
Facility Name
IDIAP Jordi Gol
City
Reus
State/Province
Tarragona
Country
Spain
Facility Name
Hospital de Tarragona Joan XXIII
City
Tarragona
ZIP/Postal Code
43005
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Motivational Approach to Treat Childhood Obesity

We'll reach out to this number within 24 hrs